Skip to main content

Animations

MJFF Publications

1691 - 1700 of 6568 Results
Title
Year
  • Year
  • 2025
  • 2026
  • 2024
  • 2025
  • 2024
  • 2014
  • 2014
  • 2015
  • 2015
  • 2015
  • Summary Details
    OPEN
    Title: Distinct proteomic CSF profiles in genetic frontotemporal lobar degeneration
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awaf457
    Citation Count: 1
  • Summary Details
    OPEN
    Title: NeuroSuite for Long‐Term Functional and Structural Studies of Air‐Liquid Interface Cerebral Organoids
    Journal Name: Advanced Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/advs.202519893
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s disease
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2024.1431549
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Global network and local vulnerabilities underlie brain atrophy across Parkinson’s disease stages
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf432
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-024-03101-8
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Network Analysis Identifies SOD2 mRNA as a Potential Biomarker for Parkinson's Disease
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0109042
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Biochemical Assessment of Precuneus and Posterior Cingulate Gyrus in the Context of Brain Aging and Alzheimer’s Disease
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0105784
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
    Journal Name: PLOS Medicine
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pmed.1001854
    Citation Count: 125
  • Summary Details
    OPEN
    Title: Neuroimaging Analysis of the Dopamine Basis for Apathetic Behaviors in an MPTP-Lesioned Primate Model
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0132064
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Exonic Re-Sequencing of the Chromosome 2q24.3 Parkinson’s Disease Locus
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0128586
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.